Table 4.
Mortality Prediction Using Models of Clinical Variables With or Without IL-6 and IL-8 in the Derivation Set
Model and Variable | OR | 95% CI | P |
---|---|---|---|
Clinical variables | |||
Age | 0.99 | .95–1.04 | .88 |
Female sex | 2.47 | 1.01–6.04 | .05 |
Charlson Comorbidity Index | 1.12 | .75–1.66 | .55 |
Modified SOFA score | 1.32 | 1.16–1.51 | <.001 |
Clinical variables + IL-6a | |||
Age | 1.00 | .95–1.06 | .88 |
Female sex | 2.89 | 1.07–7.95 | .04 |
Charlson Comorbidity Index | 1.06 | .69–1.65 | .78 |
Modified SOFA score | 1.18 | 1.02–1.36 | .02 |
IL-6 | 3.62 | 1.97–6.66 | <.001 |
Clinical variables + IL-8b | |||
Age | 0.99 | .94–1.05 | .87 |
Female sex | 2.65 | .99–7.12 | .05 |
Charlson Comorbidity Index | 1.21 | .77–1.91 | .41 |
Modified SOFA | 1.16 | .99–1.35 | .05 |
IL-8 | 3.44 | 1.87–6.32 | <.001 |
Abbreviations: CI, confidence interval; IL, interleukin; OR, odds ratio; SOFA, Sequential Organ Failure Assessment.
aModel containing clinical variables and log10 IL-6 differed significantly by likelihood ratio test (P = 7.6 × 10−6) compared with the clinical variable model.
bModel containing clinical variables and log10 IL-8 differed significantly by likelihood ratio test (P = 1.1 × 10−5) compared with the clinical variable model.